Suppr超能文献

工程化外泌体作为光动力治疗的光敏剂递送平台。

Engineered Exosomes as a Photosensitizer Delivery Platform for Cancer Photodynamic Therapy.

机构信息

School of Pharmaceutical Science (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.

Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, UP-221005, India.

出版信息

ChemMedChem. 2022 May 18;17(10):e202200119. doi: 10.1002/cmdc.202200119. Epub 2022 Apr 22.

Abstract

Photodynamic therapy (PDT), a non-/minimally invasive cancer treatment method, has the advantages of low side effects, high selectivity, and low drug resistance. It is currently a popular cancer treatment method. However, given the shortcomings of photosensitizers such as poor photostability, poor water solubility, and short half-life in vivo when used alone, the development of photosensitizer nano-delivery platforms has always been a research hotspot to overcome these shortcomings. In the human body, various types of cells generally release bilayer extracellular vesicles known as exosomes. Compared with traditional materials, exosomes are currently an ideal drug delivery platform due to their homology, low immunogenicity, easy modification, high biocompatibility, and natural carrying capacity. Therefore, in this concept, we focus on the research status and prospects of engineered exosome-based photosensitizer nano-delivery platforms in cancer PDT.

摘要

光动力疗法(PDT)是一种非侵入性/微创癌症治疗方法,具有副作用低、选择性高、耐药性低的优点。它是目前一种流行的癌症治疗方法。然而,鉴于单独使用时光敏剂如光稳定性差、水溶性差和体内半衰期短等缺点,开发光敏剂纳米递药平台一直是克服这些缺点的研究热点。在人体内,各种类型的细胞通常会释放双层细胞外囊泡,称为外泌体。与传统材料相比,外泌体由于同源性、低免疫原性、易于修饰、高生物相容性和天然承载能力,目前是一种理想的药物递送平台。因此,在这个概念中,我们专注于基于工程化外泌体的光敏剂纳米递药平台在癌症 PDT 中的研究现状和前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验